Modified Myocardial Performance Index and Epicardial Thickness in Cases With Idiopathic Polyhydramnios

Fetal Cardiac Disorder Clinical Trial

Official title:

Comparison of the Modified Myocardial Performance Index and Epicardial Thickness in Cases With Idiopathic Polyhydramnios and in Healthy Normal Pregnancies

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05737043
• Other study ID #: 2023/4145(10675: neu)
• Status: Completed
• Phase: N/A
• Start date: July 22, 2022
• Est. completion date: February 12, 2023

Study information

• Verified date: February 2023
• Source: Necmettin Erbakan University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In cases diagnosed as idiopathic polyhydramnios and healthy pregnancy between 24-40 weeks (total number of cases (100-120)), prospective fetal echocardiography will be performed to evaluate MPI and EFT.

Description:

: gestational week, maternal age, amniotic fluid index measurement, modified myocardial performance in fetal echo and epicardial thickness of all cases will be evaluated. week of pregnancy, body mass index, fetal biometry, umbilical artery doppler, middle cerebral artery doppler measurements will be taken. Birth weight and fetal intensive care hospitalizations at the birth week of all cases will be recorded. All data will be evaluated with the appropriate statistical method.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 90
• Est. completion date: February 12, 2023
• Est. primary completion date: February 12, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria: 24-40 weeks gestational age, polyhydramnios and healthy pregnancy - Exclusion Criteria: multipl pregnancy, fetal anomaly, growth restriction, maternal chronic disease -

Related Conditions & MeSH terms

• Fetal Cardiac Disorder
• Heart Diseases
• Polyhydramnios

Intervention

Diagnostic Test:
• prenatal diagnose
we will do a fetal echo in pregnant women with polyhidramnios

Locations

Country	Name	City	State
Turkey	Necmettin Erbakan University	Konya

Sponsors (1)

Lead Sponsor	Collaborator
Necmettin Erbakan University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	neonatal and fetal outcome	Do epicardial thickness and myocardial performance index determine fetal outcome in cases with polyhdramnios?	1 year